Trials / Completed
CompletedNCT03175562
To Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Participants
A Human Repeat Insult Patch Test (HRIPT) in Healthy Subjects to Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 272 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of this clinical study is to assess the irritation and sensitisation potential of a cosmetic test product after repeated semi-occlusive patch applications to healthy human participants by following a conventional HRIPT methodology under supervision of a dermatologist.
Detailed description
The first phase of the study is an Induction Phase; a known amount of each product (test and control) is applied, under a semi-occlusive patch. Patches will remain on the skin for 48 (±2) (weekdays) or 72 (±2) (including inclusive weekends) hours during this phase. Induction phase lasts for 3 weeks. After the Induction Phase participants will enter a Rest Phase of 2 weeks duration, during which no patches are applied. After the Rest Phase, participants will return to the clinical site for the Challenge Phase. In this phase a challenge patch containing the test and control products is applied to virgin skin for 48 (±2) hours then assessed 30 minutes (maximum 1 hour) following removal, 24 (± 2) and 48 (±2) hours later.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Facial micellar cleanser | Participant will have each product applied topically via semi occlusive patch, on site by the technician. Each patch will remain in place for 48 (± 2) hours on weekdays and 72 (± 2) hours on weekends. |
| OTHER | Saline Solution: Sodium Chloride (NaCl; 0.9%) | Participant will have each product applied topically via semi occlusive patch, on site by the technician. Each patch will remain in place for 48 (± 2) hours on weekdays and 72 (± 2) hours on weekends. |
Timeline
- Start date
- 2017-03-27
- Primary completion
- 2017-05-19
- Completion
- 2017-05-19
- First posted
- 2017-06-05
- Last updated
- 2019-02-15
- Results posted
- 2019-02-15
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03175562. Inclusion in this directory is not an endorsement.